Sarasota Hospital and Suncoast Communities Blood Bank Strengthen Partnership with Help of Global Med Technologies, Inc.
July 09 2007 - 9:00AM
PR Newswire (US)
DENVER, July 9 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R),
a division of Global Med Technologies, Inc.(R) (OTC:GLOB) (BULLETIN
BOARD: GLOB) , announced today that Sarasota Memorial Hospital and
Suncoast Communities Blood Bank have enhanced their partnership by
using Wyndgate's blood bank management software. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Suncoast Communities Blood Bank in Sarasota, Florida, began using
Wyndgate's SafeTrace(R) donor management system last year to help
streamline business operations and help enhance patient safety.
When Sarasota Memorial Hospital, one of Suncoast Communities'
hospital clients, needed to upgrade its transfusion management
system, the blood bank recommended Wyndgate's SafeTrace Tx(R)
software. Suncoast Communities Blood Bank has been a customer of
Wyndgate Technologies since it purchased its SafeTrace(R) blood
bank management software in 2005. "The Wyndgate system has made it
easier for us to comply with regulatory changes. Overall we have
been satisfied with its performance and the benefits it has brought
to our organization," remarked Dr. Mark Magenheim, CEO and Medical
Director of Suncoast Communities Blood Bank. "When Sarasota
Memorial Hospital needed a new computer system for its transfusion
service, we implemented Wyndgate's SafeTrace Tx* transfusion
management system. We know that these Wyndgate products are 510(k)
cleared by the FDA and are confident of the products' quality." In
addition to supplying a qualified system, Wyndgate's integrated
products are enabling Sarasota Memorial Hospital and Suncoast
Communities Blood Bank to boost their partnership to a new level.
Wyndgate's SafeTrace and SafeTrace Tx products were designed as
Vein-to-Vein(R) products offering seamless management of
information from collection and manufacturing through final
transfusion and billing. Communication and sharing of safety
information will now be easier between the hospital and its blood
source than ever before. "It is a notable benefit to both Sarasota
Memorial Hospital and Suncoast Communities Blood Bank that
SafeTrace and SafeTrace Tx are designed to integrate seamlessly.
The reliable exchange of critical information between our systems
will help us retain our high standards of patient safety," Dr.
Magenheim stated. Thomas F. Marcinek, President and Chief Operating
Officer for Wyndgate Technologies, commented, "The goal of
Wyndgate's products is to help our customers improve their
businesses so they may provide the best possible service to their
patients and communities. Our Vein-to-Vein(R) products are designed
to help donor centers and transfusion services easily manage and
share important information as required by their businesses. We are
very pleased that these products will help Sarasota Memorial
Hospital and Suncoast Communities Blood Bank to strengthen and grow
their relationship. We have enjoyed working with Suncoast
Communities Blood Bank since 2005 and look forward to many years of
continuing this work with Sarasota Memorial Hospital." About Global
Med Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the SafeTrace Tx(R) advanced transfusion management
system and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: company, Michael I. Ruxin, M.D. of Global Med
Technologies, Inc., +1-303-238-2000; or investors, Paul Holm of
H.L. Lanzet, +1-212-888-4570, , for Global Med Technologies, Inc.
Web site: http://www.globalmedtech.com/
Copyright